Biochemistry, Genetics and Molecular Biology
Mammalian Target of Rapamycin
100%
Cancer Cell
100%
Cell Proliferation
100%
STAT3
100%
Cell Viability
100%
Cell Cycle Arrest
100%
Cell Cycle Checkpoint
100%
Programmed Cell Death
100%
Protein Kinase B
100%
Mouse Model
50%
In Vitro Study
50%
MDA-MB-468
50%
MTT Assay
50%
Flow Cytometry
50%
Immunoblotting
50%
Medicine and Dentistry
Cancer Cell
100%
Triple Negative Breast Cancer
100%
Cell Proliferation
100%
Mammalian Target of Rapamycin
100%
Cell Signaling Pathway
100%
Protein Kinase B
100%
In Vitro
33%
Neoplasm
33%
Programmed Cell Death
33%
Cell Viability
33%
Cell Cycle Arrest
33%
Cell Cycle Checkpoint
33%
Side Effect
16%
Breast Cancer
16%
Breast Cancer Cell Line
16%
Xenograft
16%
Oral Drug Administration
16%
Flow Cytometry
16%
MTT Assay
16%
Immunoblotting
16%
Sesquiterpene Lactone
16%
Keyphrases
STAT3 Signaling Pathway
100%
Triple-negative Breast Cancer Cells
100%
PI3K-AKT-mTOR Pathway
100%
Arnicolide D
100%
Breast Cancer Cell Proliferation
100%
Triple-negative Breast Cancer
50%
Apoptosis
25%
Cell Viability
25%
Tumor
12%
Therapeutic Agents
12%
Oral Administration
12%
Inhibitory Effect
12%
Flow Cytometry
12%
In Vitro Study
12%
Protein Level
12%
MDA-MB-231
12%
MTT Assay
12%
Cell Cycle Arrest
12%
Xenograft Mouse Model
12%
G2-M Cell Cycle Arrest
12%
Immunoblotting
12%
Tumor Weight
12%
Breast Cancer Subtypes
12%
Cancer Effects
12%
Sesquiterpene Lactones
12%
In Vivo Assay
12%
MDA-MB-231 Cancer Cells
12%
MDA-MB-468
12%
Pharmacology, Toxicology and Pharmaceutical Science
Triple Negative Breast Cancer
100%
Cell Viability
33%
Neoplasm
33%
Mouse Model
16%
Western Blot
16%
Flow Cytometry
16%
Side Effect
16%
Breast Cancer
16%
Sesquiterpene Lactone
16%